Genexis Biotech Secures $480K Seed Investment to Pioneer Ethical & Sustainable Biotech Solutions

We are thrilled to announce that Genexis Biotech has successfully raised $480,000 in funding—a significant milestone that fuels our mission to redefine the future of biotechnology with ethical, innovative, and sustainable solutions. Based in Vadodara, Gujarat, our company stands at the forefront of cruelty-free science by manufacturing cutting-edge proteins including cytokines, cell culture media, reagents, viral transport media, and cell detachments. Each product is meticulously designed to support healthcare and research advancements while adhering to our strict commitment to 100% animal-origin-free processes. This new round of funding will be strategically invested to enhance our robust R&D initiatives, expand our state-of-the-art laboratories, and accelerate our pioneering work in alternative proteins and precision fermentation. Our support services—ranging from strain and metabolic engineering to process development, scale-up, and tailored protein solutions—will also benefit from this capital injection, enabling us to further empower clients in pharmaceuticals, cellular agriculture, and various research sectors. The investment reflects both confidence in our visionary approach and a broader endorsement of our mission to serve humanity through sustainable, ethical science. As we chart this exciting new chapter, Genexis Biotech remains dedicated to pushing the boundaries of biotech innovation, transforming cutting-edge ideas into real-world, impactful applications. We invite our partners, clients, and the broader scientific community to join us in this journey of discovery and progress, as together, we continue to shape a future where science is both humane and revolutionary.